Európska únia - angličtina - EMA (European Medicines Agency)

intervet international bv - live myxoma-vectored rabbit-haemorrhagic-disease virus strain 009 - immunologicals - rabbits - for active immunisation of rabbits from five weeks of age onwards to reduce mortality and clinical signs of myxomatosis and to prevent mortality due to rabbit haemorrhagic disease.onset of immunity: 3 weeks.duration of immunity: 1 year.

Európska únia - angličtina - EMA (European Medicines Agency)

intervet international bv - babesia canis, inactivated, babesia rossi, inactivated - immunologicals for canidae - dogs - for active immunisation of dogs of six months of age or older against babesia canis to reduce the severity of clinical signs associated with acute babesiosis (b. canis) and anaemia as measured by packed cell volume.onset of immunity: three weeks after the basic vaccination course.duration of immunity: six months after the last (re-)vaccination.

Európska únia - angličtina - EMA (European Medicines Agency)

intervet international bv - protein do (non-toxic deletion derivative of pasteurella multocida dermonecrotic toxin), inactivated bordetella bronchiseptica cells - immunologicals for suidae - pigs (gilts and sows) - for the reduction of clinical signs of progressive atrophic rhinitis in piglets by passive oral immunisation with colostrum from dams actively immunised with the vaccine.

Európska únia - angličtina - EMA (European Medicines Agency)

intervet international bv - porcine circovirus type 2 orf2 subunit antigen - immunologicals for suidae - pigs - for the active immunisation of pigs to reduce the virus load in blood and lymphoid tissues and to reduce weight loss associated with porcine-circovirus-type-2 infection occurring during the fattening period.onset of immunity: 2 weeksduration of immunity: 22 weeks

Európska únia - angličtina - EMA (European Medicines Agency)

intervet international bv - classical swine fever virus (csfv) -e2 subunit antigen - immunologicals for suidae - pigs - active immunisation of pigs from the age of 5 weeks onwards to prevent mortality and to reduce clinical signs of classical swine fever, as well as to reduce infection with and excretion of csf field virus.the onset of protection is 2 weeks.the duration of protection is 6 months.

Európska únia - angličtina - EMA (European Medicines Agency)

intervet international bv - f4ab (k88ab) fimbrial adhesin, f4ac (k88ac) fimbrial adhesin, f5 (k99) fimbrial adhesin, f6 (987p) fimbrial adhesin, lt toxoid - immunologicals - pigs (gilts and sows) - for the passive immunisation of piglets by active immunisation of sows / gilts to reduce mortality and clinical signs such as diarrhoea due to neonatal enterotoxicosis during the first days of life, caused by those e.coli strains which express the fimbrial adhesins f4ab (k88ab), f4ac (k88ac), f5 (k99) or f6 (987p).

Európska únia - angličtina - EMA (European Medicines Agency)

intervet international bv - resocortol butyrate - corticosteroids, dermatological preparations - dogs - treatment of acute localised moist dermatitis.

Izrael - angličtina - Ministry of Health

intervet ( israel) ltd - fluralaner - spot-on solution - fluralaner 280 mg / 1 ml - for the treatment of tick and flea infestations in dogs.this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and persistent flea (ctenocephalides felis and ctenocephalides canis) killing activity for 12 weeks, and- immediate and persistent tick (ixodes ricinus, rhipicephalus sanguineus and dermacentor reticulatus) killing activity for 12 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

Izrael - angličtina - Ministry of Health

intervet ( israel) ltd - fluralaner - spot-on solution - fluralaner 280 mg / 1 ml - for the treatment of tick and flea infestations in dogs.this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and persistent flea (ctenocephalides felis and ctenocephalides canis) killing activity for 12 weeks, and- immediate and persistent tick (ixodes ricinus, rhipicephalus sanguineus and dermacentor reticulatus) killing activity for 12 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

Izrael - angličtina - Ministry of Health

intervet ( israel) ltd - fluralaner - spot-on solution - fluralaner 280 mg / 1 ml - for the treatment of tick and flea infestations in dogs.this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and persistent flea (ctenocephalides felis and ctenocephalides canis) killing activity for 12 weeks, and- immediate and persistent tick (ixodes ricinus, rhipicephalus sanguineus and dermacentor reticulatus) killing activity for 12 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.